FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma

The US FDA provided updated information to women with breast implants and their health care providers on the risk of developing a specific type of lymphoma.

from Latest articles from Cancer Therapy Advisor News http://bit.ly/2Ig79eO